Abm Therapeutics
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4445 Eastgate Mall Ste 200, San Diego, C...Website
www.abmtx.comRevenue
<$5 MillionIndustry
About Abm Therapeutics
Abm Therapeutics Org Chart
Is Abm Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Abm Therapeutics has new funding data
Click to see if Abm Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Abm Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Abm Therapeutics
Check out if Abm Therapeutics is spiking on competitors!
Check if Abm Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Abm Therapeutics launches new products
Abm Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Abm Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Abm Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Abm Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Abm Therapeutics.
Abm Therapeutics Tech Stack
A closer look at the technologies used by Abm Therapeutics
Abm Therapeutics News & Media
ABM Therapeutics Announces First Patient Dosed in Phase I Study of ABM-1310 in patients with BRAF V600 in Relapsed and Drug Resistant Primary Malignant Brain Tumors
SAN DIEGO, Calif. and SHANGHAI, Sept. 1, 2023 /PRNewswire/ -- ABM Therapeutics, a clinical-stage biopharmaceutical company, today announced that the first patient has been successfully dosed in its multicenter Phase I study of ABM-1310 in patients with relapsed and drug resistant primary...U.S. FDA Grants Orphan Drug Designation to ABM-1310 for the Treatment of Patients with Glioblastoma Harboring BRAF V600 Mutation
SAN DIEGO and SHANGHAI, Aug. 2, 2023 /PRNewswire/ -- ABM Therapeutics (ABM) announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ABM-1310, a novel small molecule BRAF inhibitor developed by the company, for the treatment of patients...Latest Updates of 9 Viva's Portfolio Companies
HONG KONG, June 2, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization. Recently, 9 of Viva's portfolio companies have achieved significant results and progress. Keep reading for more details. Triumvira to Present Phase I/II Data of TAC01-HER2 in ClLatest Updates of 9 Viva's Portfolio Companies
HONG KONG, June 2, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and...
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Abm Therapeutics
ABM Therapeutics is a leading innovative drug discovery company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain metastasis from lung cancer, breast cancer and melanoma. Founded by an experienced group of scientists and entrepreneurs with successful track record, the company is... Read More